Metraipolis › archive › dc_250c5978bc71

The Effect of Bevacizumab Therapy on Reducing Erythrocyte Transfusion Requirements and Preventing Iron Deficiency in Patients With Hereditary Hemorrhagic… — Europe PMC PMID:41769502

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41769502
DOI
10.7759/cureus.102365
License (as archived)
solo-consultazione
Archived
2026-11-06T11:51:09.782Z
SHA-256 of the archived text
e60f513ae0cf738120ca335df21371096cbbeb6bd4d2d1e03fb1a89cb3780e19
Stable URL of this page
https://metraipolis.com/documento/dc_250c5978bc71

How to cite

The Effect of Bevacizumab Therapy on Reducing Erythrocyte Transfusion Requirements and Preventing Iron Deficiency in Patients With Hereditary Hemorrhagic… — Europe PMC PMID:41769502 — Europe PMC (en), https://europepmc.org/article/MED/41769502 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_250c5978bc71 (Metraipolis archive dc_250c5978bc71, sha256 e60f513ae0cf738120ca335df21371096cbbeb6bd4d2d1e03fb1a89cb3780e19)
BibTeX
@misc{dc250c5978bc71,
  title = {The Effect of Bevacizumab Therapy on Reducing Erythrocyte Transfusion Requirements and Preventing Iron Deficiency in Patients With Hereditary Hemorrhagic… — Europe PMC PMID:41769502},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41769502},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_250c5978bc71; sha256 e60f513ae0cf738120ca335df21371096cbbeb6bd4d2d1e03fb1a89cb3780e19},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41769502. Agents can read the archived copy with the MCP tool read_document.